UBX: Unity Biotechnology, Inc. Stock

by  •  • Comments Off on UBX: Unity Biotechnology, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 15.27
Enterprise Value ($M) 7.27
Book Value ($M) -0.20
Book Value / Share -0.01
Price / Book -74.49
NCAV ($M) -12.90
NCAV / Share -0.75
Price / NCAV -1.18

Profitability (mra)
Return on Invested Capital (ROIC) -1.23
Return on Assets (ROA) -0.47
Return on Equity (ROE) -1.15

Liquidity (mrq)
Quick Ratio 1.95
Current Ratio 1.95

Balance Sheet (mrq) ($M)
Current Assets 17.65
Assets 30.35
Liabilities 30.55
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -28.47
Net Income -25.99
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -20.86
Cash from Investing 8.56
Cash from Financing 0.08

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-14 13G/A Alyeska Investment Group, L.P. 9.99 -0.53

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-08-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-12 35,738 169,652 21.07
2025-05-09 25,124 81,317 30.90
2025-05-08 30,482 66,008 46.18
2025-05-07 111,951 361,633 30.96

(click for more detail)

Similar Companies
TWST – Twist Bioscience Corporation TXMD – TherapeuticsMD, Inc.
TYRA – Tyra Biosciences, Inc. UTHR – United Therapeutics Corporation
VERV – Verve Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io